Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01587352
Title Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

uveal melanoma

Therapies

Vorinostat

Age Groups: adult
Covered Countries USA


No variant requirements are available.